0001064901-21-000001.txt : 20211103
0001064901-21-000001.hdr.sgml : 20211103
20211103182502
ACCESSION NUMBER: 0001064901-21-000001
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211103
FILED AS OF DATE: 20211103
DATE AS OF CHANGE: 20211103
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: KAY CHRISTINA
CENTRAL INDEX KEY: 0001064901
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-31668
FILM NUMBER: 211377042
MAIL ADDRESS:
STREET 1: C/O 225 LONG AVENUE
CITY: HILLSIDE
STATE: NJ
ZIP: 07205
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: INTEGRATED BIOPHARMA INC
CENTRAL INDEX KEY: 0001016504
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 222407475
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: 225 LONG AVENUE
STREET 2: BUILDING 15
CITY: HILLSIDE
STATE: NJ
ZIP: 07205
BUSINESS PHONE: 9739260816
MAIL ADDRESS:
STREET 1: 225 LONG AVENUE
STREET 2: BUILDING 15
CITY: HILLSIDE
STATE: NJ
ZIP: 07205
FORMER COMPANY:
FORMER CONFORMED NAME: INTEGRATED HEALTH TECHNOLOGIES INC
DATE OF NAME CHANGE: 20020912
FORMER COMPANY:
FORMER CONFORMED NAME: CHEM INTERNATIONAL INC
DATE OF NAME CHANGE: 19960716
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4
2021-11-03
0
0001016504
INTEGRATED BIOPHARMA INC
inbp
0001064901
KAY CHRISTINA
C/O 225 LONG AVENUE
HILLSIDE
NJ
07205
1
1
0
0
Co-Chief Executive Officer
Stock Option (right to buy)
2021-11-03
4
A
0
65000
0
A
2031-11-03
Common Stock
65000
65000
D
The Exercise Price of the Stock Option will be the closing prices of the Issuer's Common Stock five trading days after the filing of the Issuer's Quarterly Report on Form 10-Q for the period ended September 30, 2021, with the Securities and Exchange Commission.
The option vests and becomes exercisable in three equal annual installments with the first installment vesting on November 3, 2022.
/s/ Christina Kay
2021-11-03